PC

Preeti Chauhan

Active Director Director DIN 07783609
DIN 07783609 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Preeti Chauhan

Data last updated:

Preeti Chauhan is a Director at Talin Remedies Private Limited (since 2017). The company operates in Pharma. Talin Remedies Private Limited reported revenue of ₹3.11 Cr (FY 2025).

DIN 07783609
Primary Designation Director
Industry Pharma
First Appointment 15 May 2017
Oldest Company Age 9 yrs
Largest company Talin Remedies Private Limited · ₹3.11 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Talin Remedies Private Limited U74999PB2017PTC046455
Director15 May 20172017₹3.11 Cr (FY 2025)Active

Board colleagues of Preeti Chauhan

NameDINCompanyDesignation
Ravi Kumar07783607Talin Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Talin Remedies Private Limited
Premium access

Shareholding and investment profile for Preeti Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preeti Chauhan

Preeti Chauhan currently holds 1 directorship: Talin Remedies Private Limited (Director, since 15 May 2017, revenue ₹3.11 Cr (FY 2025)).

Preeti Chauhan was first appointed on 15 May 2017 as Director at Talin Remedies Private Limited.

The current boards of Preeti Chauhan's companies include Ravi Kumar (Talin Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available